How GenAI-powered platform sped up clinical trial protocols

I want to know what goes through the mind of the person at a sponsor entering site data into ct(dot)gov and thinking that blinding site names is a smart competitive edge. Soon this will no longer matter. Our team has been working hard to build technology that automatically undiscloses this information, and we will make it available to everyone. Why? First: People (patients and doctors) have the right to know where trials are running. Second: Sites themselves aren’t the innovation, and therefore not the sponsor’s competitive edge. The true edge lies in the sponsor’s relationship with sites and the quality of the asset. Transparency is the answer. Third: This practice waste times of clinical research analysts across the globe trying to reverse-engineer blinded data to unblind the site names. Everyone does it for their own project, their own company. Now we will just do it for everyone and close this gap once for all.

Decentralised Clinical Trials aren’t just the future they’re the present. Too often, myths hold back adoption, but the facts tell a different story: DCTs work across multiple therapeutic areas, patients prefer the flexibility, and regulations remain as strict as ever.   Rang Life Sciences helps you stay ahead with insights and solutions that redefine clinical research. Learn more on ranglifesciences.com   #RangLifeSciences #DecentralisedTrials #ClinicalResearch #ClinicalTrials #LifeSciencesInnovation #PatientCentricity #FutureOfResearch #ClinicalDevelopment #DigitalHealth #PharmaResearch

A major clinical research organization has launched a new AI-powered clinical trial financial suite. This and more in this week’s #LifeSciences update. https://rsm.buzz/42qrIfe

Tired of delays in tracking clinical study progress? Waiting for updates can cost you precious time in making decisions. Here’s how Image Core Lab ensures you’re always informed and in control: ✅Real-Time Monitoring ✅Integrated Data Access ✅Accelerated Outcomes Discover more about our centralized reads at https://lnkd.in/gWHF6kGH #ClinicalTrialImaging #ImageCoreLab #Biopharma #ImagingSolutions #imagecorelab #clinicalresearch #RealTimeMonitoring #CentralizedReads

Running a clinical trial is complex, but the real challenge lies beyond execution. It’s about orchestrating science, technology, teams & patients into one seamless journey, ensuring innovation translates into impact. In Clinical Operations, success isn’t measured only by timelines or budgets but by how well we connect people, data & purpose to drive meaningful outcomes for patients.

In the realm of clinical trials, the significance of real-time data cannot be overstated. Speed is paramount, yet the essence lies in the confidence of the data being utilized. The traditional static monitoring approaches are no longer viable in a landscape where each day holds immense value. Those who embrace real-time data access enjoy a pivotal edge, enabling: - Early anomaly identification to prevent escalation - Smooth adjustments during the study phase, averting costly setbacks - Enhanced patient safety through prompt oversight At ClinFocus, we are committed to providing dynamic data visibility, empowering sponsors and CROs to swiftly make informed decisions of the highest caliber. In the fiercely competitive arena of drug development, real-time data has transitioned from being a choice to an imperative. It serves as the fundamental pillar for achieving success. #RealTimeData #ClinicalDataManagement #AdaptiveTrials #LifeSciences #ClinFocus

Writing protocols without the patient? In this economy? 🤨 You’re looking at a 𝘀𝘁𝗮𝗿𝘁𝗶𝗻𝗴 𝗰𝗼𝘀𝘁 𝗼𝗳 $𝟭.𝟱𝗠 This summer we interviewed patient experts, scientists, and thought leaders across the industry. They all said the same thing: involve patients as early as possible. Even 𝗯𝗲𝗳𝗼𝗿𝗲 you write the protocol. As Sabina Kineen put it, even 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗶𝗻𝗴 𝘆𝗼𝘂𝗿 𝗲𝗻𝗱𝗽𝗼𝗶𝗻𝘁 comes from understanding the patients’ needs. To do that, the industry must 𝗯𝗿𝗲𝗮𝗸 𝘁𝗵𝗲 𝘀𝗶𝗹𝗼𝘀 between the experts involved in different stages of the drug R&D and speak to patients from the moment there’s a new molecule in the pipeline. #clinicaltrials #patientcentricity #patientjourney #LifeSciences 

High-quality, fit-for-purpose operations data to help sponsors design more efficient clinical trials. Advarra's new Study Design solution gives sponsors the data-driven insights to anticipate risks and streamline development.

Registries are no longer just clinical tools, they're becoming critical infrastructure for real-world evidence. But why do so many medtech and pharma teams still struggle to access the data they need to move faster and innovate safely? Our latest white paper explores a new model for unlocking high-quality registry data through structured health data partnerships. With contributions from: 🔹Emin Aghayev – Senior Advisor, Spine Tango 🔹Elaine Young – Director of Operations, National Joint Registry 🔹Chris Boulton – Deputy Director of Operations, National Joint Registry 🔹Christine Glover – Beyond Compliance Steering Committee 👉 Download your copy here: https://ow.ly/pq1M50WJp0j #RealWorldEvidence #HealthData #RegistryData

Too often, predictive modelling in clinical trials is framed as a recruitment shortcut. But the real value isn’t speed – it’s precision. It means defining inclusion criteria that reflect true disease expression, anticipating heterogeneity within patient populations, stratifying cohorts so that outcomes are meaningful, and forecasting progression to de-risk design and execution. Predictive modelling is about building trials smarter rather than about filling trials faster, i.e., creating the evidence base that ensures therapies succeed in the real world, not just on paper. In his latest piece, Volv Global SA Clinical Innovation Director Leon van Wouwe ruminates on moving our mindset beyond quick fixes. Read it here: https://volv.li/41eiDpA #predictivemodeling #clinicaltrialrecruitment #clinicaltrialdesign #wheretechnologymeetshuman #everyindividualmatters #volvglobal